NuCana Plc (NCNA)
NuCana Market Cap: 17.40M for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Adaptimmune Therapeutics Plc | 13.92M |
| Biodexa Pharmaceuticals Plc | 3.624M |
| Autolus Therapeutics Plc | 400.55M |
| Mereo BioPharma Group Plc | 346.62M |
| Bicycle Therapeutics Plc | 509.85M |
Market Cap Related Metrics
| Price to Book Value | 0.8587 |
| Price | 4.18 |
| Earnings Yield | -3.91K% |